e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Translational studies in chronic repair and remodelling in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis
E. Farrokhi Moshai, L. Wemeau-Stervinou, N. Cigna, J. Marchal-Somme, V. Besnard, S. Brayer, A. Fabre, A. Mailleux, B. Crestani (Paris, France)
Source:
Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Session:
Translational studies in chronic repair and remodelling in the lung
Session type:
Oral Presentation
Number:
3329
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Farrokhi Moshai, L. Wemeau-Stervinou, N. Cigna, J. Marchal-Somme, V. Besnard, S. Brayer, A. Fabre, A. Mailleux, B. Crestani (Paris, France). Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis. Eur Respir J 2013; 42: Suppl. 57, 3329
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Occupational and drug-induced ILDs
PG16 Advanced cardiopulmonary exercise testing
Related content which might interest you:
Regulation of autophagy in amiodarone induced pulmonary fibrosis
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Thymosin beta4 protects mice from bleomycin-induced damage in the lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Arginase 1 contributes to fibrogenesis in the lungs of silica-challenge mice
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Resveratrol regulates ECM remodeling in lung fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Specialized-proresolving mediators and trancriptomic signatures in bleomycin-induced lung fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
Inhalation of chlorine causes lung inflammation and airway hyperresponsiveness in a rat model of chemical-induced lung injury
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Matrix metalloproteinase-2 is protective in bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
CD39 deficiency results in increased inflammation in an animal model of pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Protective effects of Dengzhanshengmai capsules on bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2014 – ILDs 3
Year: 2014
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Olodaterol attenuates bleomycin induced lung fibrosis in mice
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept